ACUTA CAPITAL PARTNERS, LLC
CIK: 0001582844Latest portfolio: $147.3M · Q4 2025
Holdings
30
Total Value
$147.3M
New Positions
7
Closed Positions
5
Top Holdings
View All 30 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | TERNTERNS PHARMACEUTICALS INC | 637,095 | $25.7M | 17.47% | +134K | |
| 2 | PRAXPRAXIS PRECISION MEDICINES I | 83,036 | $24.5M | 16.62% | +33K | |
| 3 | CDTXCIDARA THERAPEUTICS INC | 89,145 | $19.7M | 13.37% | -52,384 | |
| 4 | OCULOCULAR THERAPEUTIX INC | 1,052,995 | $12.8M | 8.68% | -112,211 | |
| 5 | WHWKWHITEHAWK THERAPEUTICS INC | 3,410,402 | $8.3M | 5.60% | — | |
| 6 | DRUGBRIGHT MINDS BIOSCIENCES INC | 84,477 | $6.6M | 4.48% | -398 | |
| 7 | CMPXCOMPASS THERAPEUTICS INC | 1,093,300 | $5.9M | 3.99% | +253K | |
| 8 | JAZZJAZZ PHARMACEUTICALS PLC | 29,008 | $4.9M | 3.35% | +4K | |
| 9 | IM8NINSMED INC | 25,878 | $4.5M | 3.06% | -12,714 | |
| 10 | ARGXARGEN SE - ADR | 4,851 | $4.1M | 2.77% | -1,528 | |
| 11 | SRZNSURROZEN INC | 178,415 | $4.0M | 2.74% | — | |
| 12 | AMLXAMYLYX PHARMACEUTICALS INC | 333,258 | $4.0M | 2.73% | — | |
| 13 | NERVMINERVA NEUROSCIENCES | 709,500 | $2.9M | 1.94% | NEW | |
| 14 | TNGXTANGO THERAPEUTICS INC | 282,732 | $2.5M | 1.70% | NEW | |
| 15 | TSHATAYSHA GENE THERAPIES INC | 454,827 | $2.5M | 1.70% | — | |
| 16 | ZYMEZYMEWORKS INC | 80,143 | $2.1M | 1.43% | — | |
| 17 | OCSOCULIS HOLDING AG | 101,777 | $2.0M | 1.38% | — | |
| 18 | DSGNDESIGN THERAPEUTICS INC | 150,906 | $1.4M | 0.96% | NEW | |
| 19 | INBXINHIBRX BIOSCIENCES INC | 16,377 | $1.3M | 0.88% | — | |
| 20 | UTHUNITED THERAPEUTICS CORP | 2,296 | $1.1M | 0.76% | — | |
| 21 | VSTMVERASTEM INC | 143,446 | $1.1M | 0.75% | — | |
| 22 | MAZEMAZE THERAPEUTICS INC | 20,000 | $828K | 0.56% | NEW | |
| 23 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 59,280 | $781K | 0.53% | NEW | |
| 24 | STROSUTRO BIOPHARMA INC | 67,451 | $780K | 0.53% | NEW | |
| 25 | DNTHDIANTHUS THERAPEUTICS INC | 16,708 | $688K | 0.47% | -8,292 |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($2.5738244741278383e+89T)
Unknown0.0% ($196914.5T)
Filing History
Fund Information
ACUTA CAPITAL PARTNERS, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $147.3M across 30 holdings. The largest position is TERNS PHARMACEUTICALS INC (TERN), representing 17.5% of the portfolio. Compared to the previous quarter, the fund opened 7 new positions and closed 5 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.